Cornerstone Therapeutics (CRTX -2.8%) says it's retained Lazard to act as its independent financial advisor and Clifford Chance to act as its independent legal counsel to assist the Special Committee in considering purchasing the company's common stock that it does not already own for a cash price of between $6.40 and $6.70 per share.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs